Point72 Asset Management, L.P.
Position in LKFT — Lakefront Biotherapeutics NV
CIK 1603466
STAMFORD, CT
Position in LKFT
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$8,089,023
-$1,874,727 QoQ
Shares Held
269,814
-18.8% QoQ
Ownership
0.412%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#10
of 78 holders
Holding Since
Dec 2020
18 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in LKFT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Point72 Asset Management, L.P. holds $2,243,264,515 across 171 Biotechnology names. LKFT ranks #58 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ROIV |
Roivant Sciences Ltd.
|
4,473,478 | $158,316,386 | |
| 2 | CYTK |
Cytokinetics Inc
|
1,587,712 | $135,257,185 | |
| 3 | BBIO |
BridgeBio Pharma, Inc.
|
1,525,782 | $113,640,243 | |
| 4 | AXSM |
Axsome Therapeutics, Inc.
|
416,516 | $101,950,621 | |
| 5 | LEGN |
Legend Biotech Corp
|
3,076,124 | $88,838,461 | |
| 6 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
137,029 | $73,577,721 | |
| 7 | CELC |
Celcuity Inc.
|
650,916 | $68,098,831 | |
| 8 | ACAD |
Acadia Pharmaceuticals Inc
|
2,433,168 | $61,559,150 |
All Filings in LKFT
Export CSV
18 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $8,089,023 | 269,814 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $9,963,750 | 332,125 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $15,899,034 | 486,209 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $15,375,622 | 443,869 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $9,558,585 | 341,500 | Shares | Defined | 2025-08-14 | |
| 2024-03-31 | $1,729,140 | 53,700 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $6,286,481 | 154,649 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $5,987,515 | 173,300 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $35,807,960 | 880,668 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $27,650,784 | 715,600 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $2,445,338 | 55,100 | Shares | Defined | 2023-05-15 | |
| 2022-09-30 | $596,960 | 14,000 | Shares | Defined | 2022-11-14 | |
| 2022-03-31 | $31,617,796 | 509,800 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $42,113,807 | 763,900 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $6,202,719 | 117,900 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $49,060,426 | 712,156 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $35,883,699 | 465,478 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $25,655,616 | 259,200 | Shares | Defined | 2021-02-16 | |
| No filing history on record for this holder in this stock. | ||||||